Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Meindl, A. Int J Cancer, 97(4):472-80., 2002. abstract bibtex The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes BRCA1 and BRCA2 were analyzed in 989 unrelated patients from German breast/ovarian cancer families. A total of 77 BRCA1 and 63 BRCA2 distinct deleterious mutations were found in 302 patients. More than (1/3) of these mutations are novel and might be specific for the German population. Eighteen common mutations were found in 68% of cases in BRCA1 and 13 recurrent mutations in 44% of cases in BRCA2, facilitating prescreening approaches. Haplotype analysis indicate that 14 out of 20 recurrent mutations are likely originating from a common founder. An additional 50 different rare sequence variants with unknown relevance for tumorigenesis were found in 72 families. Correlation of BRCA1/BRCA2 detection rates with family history identified families with both breast and ovarian cancer to be at highest risk for BRCA1/BRCA2 mutations (43% and 10%, respectively), followed by families with at least 2 premenopausal cases of breast cancer (24% BRCA1 and 13% BRCA2 mutations). These data provide strong evidence for further predisposing genes in the German population. In breast cancer families with 2 or 3 affected females but only a single or no premenopausal case, mutations were detected with low frequencies (about 10% or less for both genes). The decision for or against molecular diagnosis is now aided by considering the expected mutation detection rates that greatly depend on family history and structure.
@article{
title = {Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population},
type = {article},
year = {2002},
identifiers = {[object Object]},
keywords = {*Genes, BRCA1,*Genes, BRCA2,*Mutation,Adult,Age of Onset,Alleles,Breast Neoplasms/epidemiology/*genetics,Comparative Study,DNA Mutational Analysis,DNA, Neoplasm/genetics,Exons/genetics,Female,Founder Effect,Frameshift Mutation,Gene Frequency,Genetic Predisposition to Disease,Genetic Screening,Germany/epidemiology,Haplotypes/genetics,Human,Male,Middle Age,Mutation, Missense,Neoplasms, Multiple Primary/epidemiology/genetics,Neoplastic Syndromes, Hereditary/epidemiology/*gen,Ovarian Neoplasms/epidemiology/genetics,Prevalence,RNA Splicing/genetics,Risk Factors,Sequence Deletion,Support, Non-U.S. Gov't},
pages = {472-80.},
volume = {97},
id = {8ed5a985-2a75-32ed-8427-3fb16b9ce255},
created = {2017-06-19T13:42:58.702Z},
file_attached = {false},
profile_id = {de68dde1-2ff3-3a4e-a214-ef424d0c7646},
group_id = {b2078731-0913-33b9-8902-a53629a24e83},
last_modified = {2017-06-19T13:42:58.818Z},
read = {false},
starred = {false},
authored = {false},
confirmed = {true},
hidden = {false},
source_type = {Journal Article},
notes = {<m:note>eng<m:linebreak/>Journal Article<m:linebreak/>Multicenter Study</m:note>},
abstract = {The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes BRCA1 and BRCA2 were analyzed in 989 unrelated patients from German breast/ovarian cancer families. A total of 77 BRCA1 and 63 BRCA2 distinct deleterious mutations were found in 302 patients. More than (1/3) of these mutations are novel and might be specific for the German population. Eighteen common mutations were found in 68% of cases in BRCA1 and 13 recurrent mutations in 44% of cases in BRCA2, facilitating prescreening approaches. Haplotype analysis indicate that 14 out of 20 recurrent mutations are likely originating from a common founder. An additional 50 different rare sequence variants with unknown relevance for tumorigenesis were found in 72 families. Correlation of BRCA1/BRCA2 detection rates with family history identified families with both breast and ovarian cancer to be at highest risk for BRCA1/BRCA2 mutations (43% and 10%, respectively), followed by families with at least 2 premenopausal cases of breast cancer (24% BRCA1 and 13% BRCA2 mutations). These data provide strong evidence for further predisposing genes in the German population. In breast cancer families with 2 or 3 affected females but only a single or no premenopausal case, mutations were detected with low frequencies (about 10% or less for both genes). The decision for or against molecular diagnosis is now aided by considering the expected mutation detection rates that greatly depend on family history and structure.},
bibtype = {article},
author = {Meindl, A},
journal = {Int J Cancer},
number = {4}
}
Downloads: 0
{"_id":"eeQd3eTpbXTCboWiP","bibbaseid":"meindl-comprehensiveanalysisof989patientswithbreastorovariancancerprovidesbrca1andbrca2mutationprofilesandfrequenciesforthegermanpopulation-2002","downloads":0,"creationDate":"2017-06-19T14:46:34.075Z","title":"Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","author_short":["Meindl, A."],"year":2002,"bibtype":"article","biburl":null,"bibdata":{"title":"Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","type":"article","year":"2002","identifiers":"[object Object]","keywords":"*Genes, BRCA1,*Genes, BRCA2,*Mutation,Adult,Age of Onset,Alleles,Breast Neoplasms/epidemiology/*genetics,Comparative Study,DNA Mutational Analysis,DNA, Neoplasm/genetics,Exons/genetics,Female,Founder Effect,Frameshift Mutation,Gene Frequency,Genetic Predisposition to Disease,Genetic Screening,Germany/epidemiology,Haplotypes/genetics,Human,Male,Middle Age,Mutation, Missense,Neoplasms, Multiple Primary/epidemiology/genetics,Neoplastic Syndromes, Hereditary/epidemiology/*gen,Ovarian Neoplasms/epidemiology/genetics,Prevalence,RNA Splicing/genetics,Risk Factors,Sequence Deletion,Support, Non-U.S. Gov't","pages":"472-80.","volume":"97","id":"8ed5a985-2a75-32ed-8427-3fb16b9ce255","created":"2017-06-19T13:42:58.702Z","file_attached":false,"profile_id":"de68dde1-2ff3-3a4e-a214-ef424d0c7646","group_id":"b2078731-0913-33b9-8902-a53629a24e83","last_modified":"2017-06-19T13:42:58.818Z","read":false,"starred":false,"authored":false,"confirmed":"true","hidden":false,"source_type":"Journal Article","notes":"<m:note>eng<m:linebreak/>Journal Article<m:linebreak/>Multicenter Study</m:note>","abstract":"The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes BRCA1 and BRCA2 were analyzed in 989 unrelated patients from German breast/ovarian cancer families. A total of 77 BRCA1 and 63 BRCA2 distinct deleterious mutations were found in 302 patients. More than (1/3) of these mutations are novel and might be specific for the German population. Eighteen common mutations were found in 68% of cases in BRCA1 and 13 recurrent mutations in 44% of cases in BRCA2, facilitating prescreening approaches. Haplotype analysis indicate that 14 out of 20 recurrent mutations are likely originating from a common founder. An additional 50 different rare sequence variants with unknown relevance for tumorigenesis were found in 72 families. Correlation of BRCA1/BRCA2 detection rates with family history identified families with both breast and ovarian cancer to be at highest risk for BRCA1/BRCA2 mutations (43% and 10%, respectively), followed by families with at least 2 premenopausal cases of breast cancer (24% BRCA1 and 13% BRCA2 mutations). These data provide strong evidence for further predisposing genes in the German population. In breast cancer families with 2 or 3 affected females but only a single or no premenopausal case, mutations were detected with low frequencies (about 10% or less for both genes). The decision for or against molecular diagnosis is now aided by considering the expected mutation detection rates that greatly depend on family history and structure.","bibtype":"article","author":"Meindl, A","journal":"Int J Cancer","number":"4","bibtex":"@article{\n title = {Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population},\n type = {article},\n year = {2002},\n identifiers = {[object Object]},\n keywords = {*Genes, BRCA1,*Genes, BRCA2,*Mutation,Adult,Age of Onset,Alleles,Breast Neoplasms/epidemiology/*genetics,Comparative Study,DNA Mutational Analysis,DNA, Neoplasm/genetics,Exons/genetics,Female,Founder Effect,Frameshift Mutation,Gene Frequency,Genetic Predisposition to Disease,Genetic Screening,Germany/epidemiology,Haplotypes/genetics,Human,Male,Middle Age,Mutation, Missense,Neoplasms, Multiple Primary/epidemiology/genetics,Neoplastic Syndromes, Hereditary/epidemiology/*gen,Ovarian Neoplasms/epidemiology/genetics,Prevalence,RNA Splicing/genetics,Risk Factors,Sequence Deletion,Support, Non-U.S. Gov't},\n pages = {472-80.},\n volume = {97},\n id = {8ed5a985-2a75-32ed-8427-3fb16b9ce255},\n created = {2017-06-19T13:42:58.702Z},\n file_attached = {false},\n profile_id = {de68dde1-2ff3-3a4e-a214-ef424d0c7646},\n group_id = {b2078731-0913-33b9-8902-a53629a24e83},\n last_modified = {2017-06-19T13:42:58.818Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {true},\n hidden = {false},\n source_type = {Journal Article},\n notes = {<m:note>eng<m:linebreak/>Journal Article<m:linebreak/>Multicenter Study</m:note>},\n abstract = {The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes BRCA1 and BRCA2 were analyzed in 989 unrelated patients from German breast/ovarian cancer families. A total of 77 BRCA1 and 63 BRCA2 distinct deleterious mutations were found in 302 patients. More than (1/3) of these mutations are novel and might be specific for the German population. Eighteen common mutations were found in 68% of cases in BRCA1 and 13 recurrent mutations in 44% of cases in BRCA2, facilitating prescreening approaches. Haplotype analysis indicate that 14 out of 20 recurrent mutations are likely originating from a common founder. An additional 50 different rare sequence variants with unknown relevance for tumorigenesis were found in 72 families. Correlation of BRCA1/BRCA2 detection rates with family history identified families with both breast and ovarian cancer to be at highest risk for BRCA1/BRCA2 mutations (43% and 10%, respectively), followed by families with at least 2 premenopausal cases of breast cancer (24% BRCA1 and 13% BRCA2 mutations). These data provide strong evidence for further predisposing genes in the German population. In breast cancer families with 2 or 3 affected females but only a single or no premenopausal case, mutations were detected with low frequencies (about 10% or less for both genes). The decision for or against molecular diagnosis is now aided by considering the expected mutation detection rates that greatly depend on family history and structure.},\n bibtype = {article},\n author = {Meindl, A},\n journal = {Int J Cancer},\n number = {4}\n}","author_short":["Meindl, A."],"bibbaseid":"meindl-comprehensiveanalysisof989patientswithbreastorovariancancerprovidesbrca1andbrca2mutationprofilesandfrequenciesforthegermanpopulation-2002","role":"author","urls":{},"keyword":["*Genes","BRCA1","*Genes","BRCA2","*Mutation","Adult","Age of Onset","Alleles","Breast Neoplasms/epidemiology/*genetics","Comparative Study","DNA Mutational Analysis","DNA","Neoplasm/genetics","Exons/genetics","Female","Founder Effect","Frameshift Mutation","Gene Frequency","Genetic Predisposition to Disease","Genetic Screening","Germany/epidemiology","Haplotypes/genetics","Human","Male","Middle Age","Mutation","Missense","Neoplasms","Multiple Primary/epidemiology/genetics","Neoplastic Syndromes","Hereditary/epidemiology/*gen","Ovarian Neoplasms/epidemiology/genetics","Prevalence","RNA Splicing/genetics","Risk Factors","Sequence Deletion","Support","Non-U.S. Gov't"],"downloads":0},"search_terms":["comprehensive","analysis","989","patients","breast","ovarian","cancer","provides","brca1","brca2","mutation","profiles","frequencies","german","population","meindl"],"keywords":["*genes","brca1","*genes","brca2","*mutation","adult","age of onset","alleles","breast neoplasms/epidemiology/*genetics","comparative study","dna mutational analysis","dna","neoplasm/genetics","exons/genetics","female","founder effect","frameshift mutation","gene frequency","genetic predisposition to disease","genetic screening","germany/epidemiology","haplotypes/genetics","human","male","middle age","mutation","missense","neoplasms","multiple primary/epidemiology/genetics","neoplastic syndromes","hereditary/epidemiology/*gen","ovarian neoplasms/epidemiology/genetics","prevalence","rna splicing/genetics","risk factors","sequence deletion","support","non-u.s. gov't"],"authorIDs":[]}